| |
|
|
New Warnings About the Birth Control Patch
| By Keris KrennHrubec and Diana Zuckerman, PhD |
July 2008 |
When choosing a method of birth control, most women want what
is the most effective and convenient. Women who want "hormonal"
birth control can choose a pill, patch, injection, or vaginal
ring. Using hormones for birth control has various benefits and
risks. Scientists are starting to discover that not all of these
options have equal risks. The Patch, Ortho Evra, is now shown
to put women at greater risks than birth control pills did by
exposing women to high levels of estrogen, and because of this
some doctors are calling for its withdrawal from the market. How
does Ortho Evra work, and why is it more dangerous than other
forms of birth control?
Hormones and Birth Control
Hormonal birth control has either an estrogen and progestin combination,
or just progestin alone. These are the two hormones naturally
produced by a woman's body that cause her to have her period.
When this type of birth control is used, an artificial stream
of hormones is pumped into the body. This keeps your ovaries from
releasing new eggs during a menstrual cycle, and consequently
keeps a woman from getting pregnant.
Ortho Evra
While the Pill goes through your digestive system, hormones from
the Patch are absorbed through the skin, much like a nicotine
patch. Users of the Patch apply one patch a week for three weeks,
and then have an "off week", just as they would if they were on
the Pill.
Research scientists are discovering, however, that there are many
ways that Ortho Evra is not like the Pill. Traditional birth control
pills release about 35 micrograms of estrogen a day, which is
a safe amount. In high doses estrogen can be dangerous, with side
effects such as blood clots, strokes, and heart attacks. All hormonal
birth control methods have these side effects, so women who smoke
or who are at risk for heart disease are warned about using them.
New research is showing that Ortho Evra exposes a woman to about
60% more estrogen than the Pill, an amount that can increase these
side effects and be extremely dangerous for some women.
FDA Updates Ortho Evra Label
On January 18, 2008, the Food and Drug Administration (FDA) announced
that the Ortho Evra label must include a warning about the increased
risk of serious blood clots that can result in a pulmonary embolism
(sudden blockage of an artery in the lung) and possibly cause
death.1 The results of a study sponsored
by Johnson & Johnson (the company that makes Ortho Evra), showed
that women aged 15 - 44 who were on the Patch were at a much greater
risk for developing blood clots than women on the Pill.1
A recent research review showed that women who used the Patch
experienced more side effects such as nausea, vomiting, bleeding
between periods, and breast discomfort than women who were on
the Pill or the Ring.2 Patch users
were also more likely to stop using their birth control and switch
to a different kind due to these uncomfortable side effects.2
This is the second time that the Ortho Evra label has been changed
to include new warnings since it went on sale in 2002. In 2006,
the FDA recommended that a warning be added about the increased
risk of blood clots when on the Patch, and women have become increasingly
concerned about their safety while using the Patch.
Who Should Not Take Ortho Evra?
While the FDA still maintains that the Patch is a safe choice
for some women, other people are not so sure. There are currently
many lawsuits against Johnson & Johnson on behalf of otherwise
healthy women who were harmed or died while using the Patch. The
update of the warning label of Ortho Evra was partly due to Canadian
reports of two deaths, one heart attack, and 16 patients with
blood clots since 2004 among those using Ortho Evra.
For women who are not at risk for blood clots or stroke, the FDA
still defends Ortho Evra as a safe birth control method. However,
the FDA recommends that all women, especially women who smoke
or are at risk for blood clots, carefully consider with their
health care provider which method of birth control is best for
them. Perhaps the most important question is: why take a risk
with the Patch when safer alternatives are available?
References
1 FDA News. (2008, January 18). FDA Approves Update
to Label on Birth Control Patch. Retrieved from: http://www.fda.gov/bbs/topics/NEWS/2008/NEW01781.html
2 Lopez, LM. (2003). Skin patch and vaginal ring
versus combined oral contraceptives for contraception. The Cochrane
Database of Systematic Reviews. 1.
|
|
|